These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12720172)

  • 21. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
    Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
    Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
    Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [K-ras gene mutation in gallbladder carcinoma].
    Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O
    Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
    Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
    Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of K-ras mutations in biliary duct carcinomas of cases with a long common channel in the papilla of Vater.
    Hidaka E; Yanagisawa A; Seki M; Takano K; Setoguchi T; Kato Y
    Cancer Res; 2000 Feb; 60(3):522-4. PubMed ID: 10676628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients.
    Yoo J; Robinson RA
    Cancer; 1999 Jul; 86(1):58-63. PubMed ID: 10391564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in pancreaticobiliary maljunction.
    Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
    J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point mutations of the c-Ki-ras gene in carcinoma and atypical epithelium associated with congenital biliary dilation.
    Tomono H; Nimura Y; Aono K; Nakashima I; Iwamoto T; Nakashima N
    Am J Gastroenterol; 1996 Jun; 91(6):1211-4. PubMed ID: 8651173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double cancer of gall bladder and bile duct not associated with anomalous junction of the pancreaticobiliary duct system.
    Hori H; Ajiki T; Fujita T; Okazaki T; Suzuki Y; Kuroda Y; Fujimori T
    Jpn J Clin Oncol; 2006 Oct; 36(10):638-42. PubMed ID: 16908513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-leiden).
    de vos tot Nederveen Cappel WH; Offerhaus GJ; van Puijenbroek M; Caspers E; Gruis NA; De Snoo FA; Lamers CB; Griffioen G; Bergman W; Vasen HF; Morreau H
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3598-605. PubMed ID: 14506146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic.
    Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC
    JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Frequency of K-ras mutation in biliary and pancreatic tumors].
    Roa JC; Anabalón L; Tapia O; Melo A; de Aretxabala X; Roa I
    Rev Med Chil; 2005 Dec; 133(12):1434-40. PubMed ID: 16446870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliary papillomatosis arising in a congenital choledochal cyst: report of a case.
    Iwasaki Y; Shimoda M; Furihata T; Rokkaku K; Sakuma A; Ichikawa K; Fujimori T; Kubota K
    Surg Today; 2002; 32(11):1019-22. PubMed ID: 12444445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
    Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
    Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and characterisation of six human biliary tract cancer cell lines.
    Ku JL; Yoon KA; Kim IJ; Kim WH; Jang JY; Suh KS; Kim SW; Park YH; Hwang JH; Yoon YB; Park JG
    Br J Cancer; 2002 Jul; 87(2):187-93. PubMed ID: 12107841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
    Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
    Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China.
    Rashid A; Ueki T; Gao YT; Houlihan PS; Wallace C; Wang BS; Shen MC; Deng J; Hsing AW
    Clin Cancer Res; 2002 Oct; 8(10):3156-63. PubMed ID: 12374683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers.
    Toyooka S; Tokumo M; Shigematsu H; Matsuo K; Asano H; Tomii K; Ichihara S; Suzuki M; Aoe M; Date H; Gazdar AF; Shimizu N
    Cancer Res; 2006 Feb; 66(3):1371-5. PubMed ID: 16452191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.